CMBA
COLL icon

C.M. Bidwell & Associates’s Collegium Pharmaceutical COLL Stock Holding History

C.M. Bidwell & Associates’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,770
Closed -$127K – 404
2020
Q1 		$127K Buy
+7,770
New +$160K 0.13% 144

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

C.M. Bidwell & Associates's COLL Position: Q2 2020 in Review

C.M. Bidwell & Associates sold out of Collegium Pharmaceutical (COLL) in Q2 2020, closing a stake of 7,770 shares — an estimated $127K sold.

C.M. Bidwell & Associates first reported a position in COLL in Q1 2020 and held it in 1 quarter. The position peaked at $127K in Q1 2020. 150 funds tracked by Wall St. Rank hold COLL as of Q2 2020.

  • C.M. Bidwell & Associates reported no remaining Collegium Pharmaceutical position as of Q2 2020 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 7,770 Collegium Pharmaceutical shares in Q2 2020, an estimated $127K.
  • C.M. Bidwell & Associates first reported a position in Collegium Pharmaceutical in Q1 2020 and held it in 1 quarter.
  • C.M. Bidwell & Associates's Collegium Pharmaceutical position peaked at $127K in Q1 2020.
  • 150 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2020.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2020, filed 14 Aug 2020.